AL AMYLOIDOSIS
Clinical trials for AL AMYLOIDOSIS explained in plain language.
Never miss a new study
Get alerted when new AL AMYLOIDOSIS trials appear
Sign up with your email to follow new studies for AL AMYLOIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New antibody could clear toxic proteins from organs in rare disease
Disease control OngoingThis study tests a drug called CAEL-101 in people with AL amyloidosis, a rare disease where abnormal proteins build up in organs like the heart and kidneys. The drug is designed to remove these protein deposits. The trial includes 281 participants who have not had prior treatment…
Matched conditions: AL AMYLOIDOSIS
Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 01, 2026 20:12 UTC
-
New antibody therapy targets tough AL amyloidosis cases
Disease control TerminatedThis study was designed to test a drug called CM-336 in people with AL amyloidosis whose disease came back or didn't get better enough after initial treatment. The drug works by helping the immune system attack harmful cells. The trial was withdrawn before enrolling any participa…
Matched conditions: AL AMYLOIDOSIS
Phase: NA • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 01, 2026 15:59 UTC
-
New antibody aims to clear toxic protein clumps in fatal organ disease
Disease control OngoingThis study tests an experimental drug called CAEL-101 in people with a rare disease called AL amyloidosis, where abnormal proteins build up in organs like the heart and kidneys. The drug is designed to remove those protein deposits. The trial includes 125 patients with advanced d…
Matched conditions: AL AMYLOIDOSIS
Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC